GTPase Ral Ralを標的とする小分子を発見し,特徴づけました
Chao Yan1, Degang Liu2, Liwei Li2
1Department of Surgery, University of Colorado, Aurora, Colorado 80045, USA.
Nature
|September 16, 2014
まとめ
研究者らは,腫瘍の成長に不可欠なRal GTPasesを阻害する新しい化合物を特定しました. これらの分子は,Ral依存がんを標的とした研究ツールと潜在的ながん治療薬として有望を示しています.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
背景:
- ラス型GTPasesRalAとRalBは,腫瘍の進行と転移の重要なレギュレータである.
- Ral GTPaseの機能をターゲットにすることは,がん治療の治療戦略を示しています.
研究 の 目的:
- Ral GTPaseの活性を阻害する小分子を特定し,特徴づけること.
- これらの阻害剤を潜在的な抗がん剤として検証する.
主な方法:
- 構造ベースの薬物設計と仮想スクリーニングを使用して,Ral阻害剤を特定しました.
- バイオケミカルアッセイ (同熱タイトレーションカロメトリー,表面プラズモン共鳴) と細胞ベースのアッセイが検証に使用されました.
- 腫瘍の異種移植を用いた in vivo 試験では,治療効果が評価されました.
主要な成果:
- 新しい化合物 (RBC6,RBC8,RBC10) が,Ralエフェクタ結合とRal媒介細胞プロセスを阻害することを特定しました.
- 化合物BQU57はRalBに特定の結合を示し,これは生体物理学的技術によって確認されました.
- 阻害剤は,RasとRhoAGTPasesよりもRalに対する選択性を示した.
- 化合物は,腫瘍の異種移植の成長を in vivo で効果的に抑制しました.
結論:
- 構造ベースの発見は,Ral依存性がんを標的とした治療法の開発に有効です.
- 特定されたRal阻害剤は,貴重な研究ツールと潜在的な薬剤候補として機能します.
関連する概念動画
Small GTPases - Ras and Rho
4.4K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.4K
Rab Proteins
4.0K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.0K
GTPases and their Regulation
7.9K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
7.9K
GTPases and their Regulation
2.4K
2.4K
Rab Cascades
2.8K
Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
2.8K
The Ras Gene
5.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
5.7K


